| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.0007 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0007 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0008 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |